FDA Identifies Need For Updated Chemical-Evaluation Processes In CFSAN
This article was originally published in The Tan Sheet
Executive Summary
FDA says it will look to update processes across CFSAN divisions, including its cosmetics office, for assessing and sharing information related to chemical hazards, following completion of a review that included interviews with current and former FDAers and consultation with outside experts. In its report, CFSAN prioritizes an in silico system that would house chemical-risk-assessment data and use predictive tools to provide centers with safety signals related to substances used in cosmetics, dietary supplements and other regulated products.